ATAC-Seq Protocol for MCF7 and LOXIMVI
Corresponding Organization : Harvard University
Other organizations : University of Pittsburgh Medical Center, UPMC Hillman Cancer Center
Variable analysis
- Use of MuA transposase rather than TN5 transposase
- ATAC-seq data (sequencing reads)
- Cell lines (MCF7 and LOXIMVI)
- Cell number (50K cells)
- Lysis buffer (0.1% NP-40 in hypotonic buffer)
- Transposition reaction conditions (30 μl volume, 0.7 μl MuA, 10 μl MuA buffer, 19 μl H2O, 5 min at 30°C)
- Stop solution (3 μl)
- Purification using SPRI beads
- PCR amplification with barcoded adaptors
- Sequencing (single end 75 bp reads on Illumina NextSeq)
- Genomic DNA (50 ng) from MCF7 and LOXIMVI transposed, amplified, and sequenced in parallel to estimate background
- None explicitly mentioned
Annotations
Based on most similar protocols
As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!